Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer von Mortensen, Anja Charlotte Lundgren, Berglund, Hanna, Hariri, Mehran, Papalanis, Eleftherios, Malmberg, Christer, Spiegelberg, Diana

Volltext

The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model von Spiegelberg, Diana, Mortensen, Anja Charlotte Lundgren, Palupi, Kartika Dyah, Micke, Patrick, Wong, Julin, Vojtesek, Borivoj, Lane, David Philip, Nestor, Marika

Volltext

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach von Spiegelberg, Diana, Abramenkovs, Andris, Mortensen, Anja Charlotte Lundgren, Lundsten, Sara, Nestor, Marika, Stenerlöw, Bo

Volltext

Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib von Mortensen, Anja Charlotte Lundgren, Mohajershojai, Tabassom, Hariri, Mehran, Pettersson, Marika, Spiegelberg, Diana

Volltext

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells von Mortensen, Anja Charlotte Lundgren, Spiegelberg, Diana, Brown, Christopher John, Lane, David Philip, Nestor, Marika

Volltext

Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer von Lundgren Mortensen, Anja Charlotte, Berglund, Hanna, Hariri, Mehran, Papalanis, Eleftherios, Malmberg, Christer, Spiegelberg, Diana

Volltext bestellen

The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model von Spiegelberg, Diana, Lundgren Mortensen, Anja Charlotte, Palupi, Kartika Dyah, Micke, Patrick, Wong, Julin, Vojtesek, Borivoj, Lane, David Philip, Nestor, Marika

Volltext bestellen